MRK—PDUFA date for Keytruda monotherapy in third-line gastric cancer is 9/22/17 (with priority review): http://www.businesswire.com/news/home/20170523005508/en/FDA-Grants-Priority-Review-Merck%E2%80%99s-Supplemental-Biologics